Magnasense Press Releace

Investors

Contact

For questions related to Investor Relations, please contact:

Email: ir@subgen.ai

2023-12-20 15:56 AegirBio AB: Atlas Special Opportunities, LLC påkallar partiell konvertering av utestående konvertibler till ett nominellt belopp om 5,00 MSEK Regulatory MAR
2023-11-24 08:18 AegirBio avger delårsrapport och redogör för väsentliga händelser Regulatory MAR
2023-11-03 14:08 AegirBio AB utser Christel Dahlberg till CFO Regulatory
2023-11-01 08:45 AegirBio AB Receives $239,547 award from the National Institutes of Health RADx Tech Program Regulatory
2023-11-01 08:35 AegirBio focuses on RadX project, will not uphold CE-markings for the MagniaReader TDM tests Regulatory MAR
2023-10-30 10:23 Interview with AegirBio CEO Mr Marco Witteveen
2023-10-09 08:00 AegirBio promotes Dr. Vasiliki Fragkou to Chief Operating Officer from November 1, 2023. Regulatory
PreviousNext

Contact

For questions related to Investor Relations, please contact:

Email: ir@subgen.ai

Subscribe to our press releases

By clicking the Sign Up button, you agree to the privacy policy

en_USEN
en_USEN es_ESES
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.